GlassScriptPhysician profile
Connie Klotzbach
NPI 1225576820
$19,645.86
in general payments reported to CMS, 2019-2025
58 companies · $4,226 in 2025
The $4,226 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,919 · 2022: $4,706 · 2023: $2,938 · 2024: $3,857 · 2025: $4,226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $41.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,979.70 |
| Education | $41.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,862.72 | 2021-2025 | |
| Ucb, INC. | $1,254.64 | 2021-2025 | Zilbrysq, Briviact, Fintepla |
| Novartis Pharmaceuticals Corporation | $1,188.98 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $1,105.12 | 2021-2025 | Ultomiris, Soliris |
| Acadia Pharmaceuticals INC | $1,051.57 | 2021-2025 | Nuplazid |
| Sk Life Science, INC. | $1,045.66 | 2021-2025 | |
| Emd Serono, INC. | $852.34 | 2021-2025 | Mavenclad, Mavenclad |
| Pfizer INC. | $751.47 | 2023-2025 | |
| Genentech USA, INC. | $624.28 | 2021-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Neurocrine Biosciences, INC. | $611.59 | 2021-2025 | Ingrezza, Ongentys |
| Teva Pharmaceuticals USA, INC. | $572.06 | 2021-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Biogen, INC. | $550.58 | 2021-2025 | Vumerity, Tysabri |
| Janssen Pharmaceuticals, INC | $514.14 | 2021-2023 | Ponvory |
| Lilly USA, LLC | $491.28 | 2021-2025 | Emgality, Amyvid, Kisunla |
| Lundbeck LLC | $487.10 | 2021-2025 | Vyepti |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Klotzbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.